↓ Skip to main content

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

Overview of attention for article published in Diabetologia, March 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy
1 policy source
twitter
1 tweeter
patent
1 patent

Citations

dimensions_citation
216 Dimensions

Readers on

mendeley
114 Mendeley
citeulike
1 CiteULike
Title
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
Published in
Diabetologia, March 2006
DOI 10.1007/s00125-006-0176-9
Pubmed ID
Authors

J. M. M. Evans, S. A. Ogston, A. Emslie-Smith, A. D. Morris

Abstract

The aim of this study was to evaluate the risk of adverse cardiovascular outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 3%
Spain 2 2%
Brazil 1 <1%
Ireland 1 <1%
United States 1 <1%
Unknown 106 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 19%
Student > Master 16 14%
Student > Bachelor 16 14%
Researcher 14 12%
Other 13 11%
Other 32 28%
Unknown 1 <1%
Readers by discipline Count As %
Medicine and Dentistry 59 52%
Agricultural and Biological Sciences 18 16%
Unspecified 9 8%
Biochemistry, Genetics and Molecular Biology 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 15 13%
Unknown 1 <1%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2016.
All research outputs
#1,858,982
of 12,225,951 outputs
Outputs from Diabetologia
#936
of 3,621 outputs
Outputs of similar age
#35,390
of 221,637 outputs
Outputs of similar age from Diabetologia
#8
of 44 outputs
Altmetric has tracked 12,225,951 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,621 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.1. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,637 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.